Mutsuo Kuba, MD

Articles by Mutsuo Kuba, MD

UFT Plus Cisplatin in Advanced Non-Small-Cell Lung Cancer: Interim Analysis of 67 Patients

ByTokujiro Yano, MD,Shoji Kudoh, MD,Kozo Yoshimori, MD,Tetsuyuki Morikawa, MD,Mutsuo Kuba, MD,Hisanobu Niitani, MD

September 2nd 1997

A single-institution phase II study indicated that combination chemotherapy using UFT (tegafur and uracil) plus cisplatin (Platinol) in patients with non-small-cell lung cancer was active with less host toxicity than other cisplatin-

Latest Updated Articles

UFT Plus Cisplatin in Advanced Non-Small-Cell Lung Cancer: Interim Analysis of 67 Patients
September 2nd 1997

Mutsuo Kuba, MD

Articles by Mutsuo Kuba, MD

UFT Plus Cisplatin in Advanced Non-Small-Cell Lung Cancer: Interim Analysis of 67 Patients

Latest Updated Articles

Trending on CancerNetwork

FDA Advisory Committee Backs RP1/Nivolumab for Advanced Melanoma

FDA OKs Lutetium Lu 177 Vipivotide Tetraxetan in Metastatic Prostate Cancer

Subcutaneous Amivantamab Receives FDA Priority Review in R/M HNSCC

How KRAS-Targeted Therapy May Advance Toward Cancer Prevention

CAR T-Cell Therapy Could Soon Expand Into Non-Oncology Indications